1. Home
  2. GBDC vs LIVN Comparison

GBDC vs LIVN Comparison

Compare GBDC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

HOLD

Current Price

$12.67

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

N/A

Current Price

$62.55

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GBDC
LIVN
Founded
2007
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
GBDC
LIVN
Price
$12.67
$62.55
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$14.17
$72.43
AVG Volume (30 Days)
2.2M
687.4K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
12.27%
N/A
EPS Growth
4.41
N/A
EPS
0.25
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.79
Revenue Next Year
N/A
$6.89
P/E Ratio
$50.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.77
$34.00
52 Week High
$15.63
$71.58

Technical Indicators

Market Signals
Indicator
GBDC
LIVN
Relative Strength Index (RSI) 53.93 45.33
Support Level $12.25 $61.60
Resistance Level $14.03 $65.25
Average True Range (ATR) 0.27 1.95
MACD 0.03 0.08
Stochastic Oscillator 63.40 30.61

Price Performance

Historical Comparison
GBDC
LIVN

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: